Characteristics of EGFR family-mediated HRG signals in human ovarian cancer

Journal of Cellular Biochemistry

Volumn 73, Issue 4, 1999, Pages 522-532

  Campiglio, Manuela ^a,b   Ali, Suhad ^a   Knyazev, Piotr G ^a   Ullrich, Axel ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

EGF; EGFR family; HRG; Ovarian cancer; Signal transduction

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; NEU DIFFERENTIATION FACTOR; RECEPTOR ANTIBODY; THYMIDINE; TRITIUM; TYROSINE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; MITOGENESIS; ONCOGENE NEU; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

DNA REPLICATION; ENZYME ACTIVATION; FEMALE; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NEUREGULIN-1; OVARIAN NEOPLASMS; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TYROSINE;

FALLOPIA; TRITIUM;

EID: 0033564604     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990615)73:4<522::AID-JCB10>3.0.CO;2-4     Document Type: Article

References (45)

1. Alimandi M, Romano A, Curia MC, Muraro R, Fedi P, Aaronson SA, Di Fiore PP, Kraus MH. 1995. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene 10: 1813-1821.
2. Alimandi M, Wang LM, Bottaro D, Lee CC, Kuo A, Frankel M, Fedi P, Tang C, Lippman M, Pierce JH. 1997. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors. EMBO J 16:5608-5617.
3. Beerli RR, Graus-Porta D, Woods-Cook K, Chen XM, Yarden Y, Hynes NE. 1995. Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2. Mol Cell Biol 15: 6496-6505.
4. Ben-Baruch N, Yarden Y. 1994, Neu differentiation factors: A family of alternative spliced neuronal and mesenchymal factors. Proc Soc Exp Biol Med 206:221-227.
5. Carraway KL, III, Sliwkowski MX, Akita R, Platko JV, Guy PM, Nuijens A, Diamonti AJ, Vandlen RL, Cantley LC, Cerione RA. 1994. The erbB3 gene product is a receptor for heregulin. J Biol Chem 269:14303-14306.
6. Chen X, Levkowitz G, Tzahar E, Karunagaram D, Levi S, Ben-Baruch N, Leitner O, Ratzkin BJ, Bacus SS, Yarden Y. 1996. An immunological approach reveals biological differences between the two NDF/Heregulin receptors ErbB-3 and ErbB-4. J Biol Chem 271:7620-7629.
7. Cohen BD, Green JM, Foy L, Fell HP. 1996. HER4-mediated biological and biochemical properties in NIH 3T3 cells. J Biol Chem 271:4813-4818.
8. Earp SH, Li H, Yu H. 1995. Heterodimerization and functional interaction between EGF receptor family members: A new signaling paradigm with implication for breast cancer research. Breast Cancer Res Treatment 35:115-132.
9. Egan SE, Weinberg RA. 1993. The pathway to signal achievement. Nature 365:781-782.
10. Goldman R, Benlevy R, Peles E, Yarden Y. 1990. Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells - A mechanism for receptor Transregulation. Biochemistry 29:11024-11028.
11. Graus-Porta D, Beerli RR, Hynes NE. 1995. Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling. Mol Cell Biol 15:1182-1191.
12. Graus-Porta D, Beerli RR, Daly JM, Hynes NE. 1997. ErbB-2, the preferred heterodimerization partner of all ErbB receptor, is a mediator of lateral signaling. EMBO J 16:1647-1655.
13. Groenen LC, Nice EC, Burgess AW. 1994. Structure-function relationships for the EGF/TGF-alpha family of mitogens. Growth Factors 11:235-257.
14. Gullick WJ. 1991. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br Med Bull 47:87-98.
15. Hanks SK, Quinn AM. 1991. Protein kinase catalytic domain sequence database: Identification of conserved features of primary structure and classification of family members. Methods Enzymol 200:38-62.
16. Hijazi MM, Mueller SC, Torri J, Coopman P, Lupu R, Thompson EW. 1994. Gp30/heregulin promotes invasive behavior and phenotype in SKBR3 cells and is blocked by gp30 polyclonal antiserum. 5th Int Congress MRS, Abstract 69. Clin Exp Metastasis 12:28.
17. Honegger AM, Kris RM, Ullrich A, Schlessinger J. 1989. Evidence that autophosphorylation of solubilized receptors for epidermal growth factor is mediated by intermolecular cross-phosphorylation. Proc Natl Acad Sci USA 86:925-929.
18. Hynes NE, Stern DF. 1994. The biology of erbB-2/neu / HER-2 and its role in cancer. Biochim Biophys Acta Rev Cancer 1198:165-184.
19. Karunagaran D, Tzahar E, Beerli RR, Chen XM, Graus-Porta D, Ratzkin BJ, Seger R, Hynes NE, Yarden Y. 1996. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: Implications for breast cancer. EMBO J 15:254-264.
20. Kim H-H, Sierke SL, Koland JG. 1994. Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product. J Biol Chem 269:24747-24755.
21. King CR, Borrello I, Bellot F, Comoglio P, Schlessinger J. 1988. EGF binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3. EMBO J 7:1647-1651.
22. Knyazev PG, Imyanitov EN, Chernitca OI, Nikiforova IF, Hanson KP. 1992. Amplification of ERBB-2 (HER-2/ NEU) oncogene in different neoplasms of patients from USSR. Oncology (Basel) 49:162-165.
23. Kramarsky RP, Soussan L, Levkowitz G, Alroy I, Klapper L, Lavi S, Seger R, Ratzkin JB, Sela M, Yarden Y. 1996. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J 15:2452-2467.
24. Kraus MH, Issing W, Miki T, Popescu NC, Aaronson SA. 1989. Isolation and characterization of erbB3, a third member of the erbB/epidermal growth factor receptor family: Evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci USA 86:9193-9197.
25. Kris RM, Lax I, Gullick W, Waterfield MD, Ullrich A, Fridkin M, Schlessinger J. 1985. Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbB protein. Cell 40:619-625.
26. Mincione G, Piccirelli A, Lazzareschi D, Salomon DS, Colletta G. 1998. Heregulin-dependent autocrine loop regulates growth of K-ras but not erbB-2 transformed rat thyroid epithelial cells. J Cell Physiol 176:383-391.
27. erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sei USA 90:1746-1750.
28. Plowman GD, Green JM, Culouscou J-M, Carlton GW, Rothwell VM, Buckley S. 1993b. Heregulin induces tyrosine phosphorylation of HER4/p180erbB4. Nature 366:473-475.
29. c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases. Proc Natl Acad Sei USA 89:1330-1334.
30. Rajkumar T, Gullick WJ. 1994. The type I growth factor receptors in human breast cancer. Breast Cancer Res Treatment 29:3-9.
31. Riese DJ, II, Van Raaij TM, Plowman GD, Andrews GC, Stern DF. 1995. The cellular response to neuregulins is governed by complex interactions of the erbB receptor family. Mol Cell Biol 15:5770-5776.
32. Riese DJ, II, Bermingham Y, Van Raaij TM, Buckley S, Plowman GD, Stern DF. 1996. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-b. Oncogene 12:345-353.
33. Riese DJ, II, Komurasaki T, Plowman GD, Stern DF. 1998. Activation of ErbB4 by the bifunctional epidermal growth factor family hormone epiregulin is regulated by ErbB2. J Biol Chem 273:11288-11294.
34. Rubin SC, Finstad CL, Wong GY, Almadrones L, Plante M, Lloyd KO. 1993. Prognostic significance of HER-2/neu expression in advanced epithelial ovarian cancer: A multivariate analysis. Am J Obstet Gynecol 168:162-169.
35. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. 1987. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177-182.
36. Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrick VD, Nuijens A, Fendly BM, Cerione RA, Vandlen RL, Carraway KL, III. 1994. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem 269:14661-14665.
37. Soltoff SP, Carraway KL, III, Prigent SA, Gullick WG, Cantley LC. 1994. ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Mol Cell Biol 14:3550-3558.
38. Toyoda H, Komurasaki T, Ikeda Y, Yoshimoto M, Morimoto S. 1998a. Molecular cloning of mouse epiregulin, a novel epidermal growth factor-related protein expressed in the early stage of development. FEBS Lett 377:403-407.
39. Toyoda H, Komurasaki T, Uchida D, Takayama Y, Isobe T, Okuyama T, Kanada K. 1998b. Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J Biol Chem 270:7495-7500.
40. Tzahar E, Levkowitz G, Karunagaran D, Yi L, Peles E, Lavi S, Chang D, Liu N, Yayon A, Wen D, Yarden Y. 1994. ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms. J Biol Chem 269:25226-25233.
41. Tzahar E, Waterman H, Chen X, Levkowitz G, Karunagaran D, Lavi S, Ratzkin BJ, Yarden Y. 1996. A hierarchinal network of intereceptor interactions determines signal transduction by neu differentiation factor/neuregulin and epidermal growth factor. Mol Cell Biol 16:5276-5287.
42. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD, Seeburg PH. 1984. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309:418-425.
43. Wada T, Qian X, Greene MI. 1990. Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function. Cell 61:1339-1347.
44. Wallasch C, Weiss FU, Niederfellner G, Jallal B, Issing W, Ullrich A. 1995. Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. EMBO J 14:4267-4275.
45. Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T, Toyoshima K. 1986. Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature 319:230-234.